Shares of Zosano Pharma Corp (NASDAQ:ZSAN) traded down 0% on Friday . The stock traded as low as $0.52 and last traded at $0.53. 583,931 shares changed hands during mid-day trading, an increase of 46% from the average session volume of 401,026 shares. The stock had previously closed at $0.53.
Separately, ValuEngine raised shares of Zosano Pharma from a “strong sell” rating to a “sell” rating in a research report on Sunday, December 31st.
Zosano Pharma (NASDAQ:ZSAN) last posted its quarterly earnings data on Thursday, November 9th. The biotechnology company reported ($0.20) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.05). research analysts expect that Zosano Pharma Corp will post -0.9 EPS for the current fiscal year.
An institutional investor recently raised its position in Zosano Pharma stock. Vanguard Group Inc. raised its position in Zosano Pharma Corp (NASDAQ:ZSAN) by 20.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,217,323 shares of the biotechnology company’s stock after buying an additional 209,251 shares during the period. Vanguard Group Inc. owned 3.11% of Zosano Pharma worth $1,716,000 as of its most recent filing with the SEC. 19.41% of the stock is owned by institutional investors and hedge funds.
WARNING: This report was posted by Markets Daily and is the property of of Markets Daily. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://www.themarketsdaily.com/2018/01/14/zosano-pharma-zsan-stock-price-down-0.html.
Zosano Pharma Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma and related companies with MarketBeat.com's FREE daily email newsletter.